SPX3,941.26-57.58 -1.44%
DIA336.46-3.57 -1.05%
IXIC11,014.89-225.05 -2.00%

Mind Medicine (MindMed) Initiated at Outperform by RBC With $5 Price Target, Speculative Risk Qualifier; Firm Sees 'Opportunity for Upside'

Mind Medicine (MindMed) Initiated at Outperform by RBC With $5 Price Target, Speculative Risk Qualifier; Firm Sees 'Opportunity for Upside'

MT Newswires · 11/16/2022 03:16

Please log in to view news